Impax Can't Shake Injunction On Generic Amrix

A Delaware federal judge on Thursday nixed Impax Laboratories Inc.'s bid to amend an injunction barring it from marketing a generic version of Cephalon Inc.'s muscle relaxant Amrix, ruling that a...

Already a subscriber? Click here to view full article